Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Extraperitoneal radical prostatectomy Da Vinci]

[Extraperitoneal radical prostatectomy Da Vinci] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Extraperitoneal radical prostatectomy Da Vinci] Abstract Text:

    h johnH John,d m schmidD M Schmid,j l fehrJ L Fehr,h johnH John,d m schmidD M Schmid,j l fehrJ L Fehr,

    OBJECTIVE: To report the outcomes of 100 robotically assisted laparoscopic radical prostatectomies (RALPs), a minimally invasive alternative for treating prostate cancer. PATIENTS AND METHODS: In all patients was used RALP with an extraperitoneal approach assisted by the da Vinci robotic surgical system (Intuitive Surgical, Sunnyvale, CA, USA). Prospective data collection included quality-of-life questionnaires, basic demographics (height, weight and body mass index), prostate specific antigen (PSA) levels, clinical stage and Gleason grade. Variables assessed during RALP were operative duration, estimated blood loss (EBL) and complications, and after RALP were hospital stay, catheter time, pathology, PSA level, return of continence and potency. RESULTS: The mean (range) duration of RALP was 180 (140-295) min; all procedures were successful, with no intraoperative transfusions or deaths. The mean EBL was 300 mL (40-1100); 97% of patients were discharged home on the first day after RALP with a mean haematocrit of 36%. The mean duration of catheterization was 7 (5-21) days. The positive margin rate was 14% for all patients. The overall biochemical recurrence free (PSA level < 0.1 ng/mL) survival was 95% at mean follow-up of 9.7 months. There was complete continence at 6 months in 95% of patients. At 1 year 78% of patients were potent (with or without the use of oral medications), 15% were not yet able to sustain erections capable of intercourse, and another 7% still required injection therapy. CONCLUSION: RALP is a safe, feasible and minimally invasive alternative for treating prostate cancer. Our initial experience with the procedure shows promising short-term outcomes.

    [Extraperitoneal radical prostatectomy Da Vinci] Publishing Authors By Initials

    h johnH John,dm schmidDM Schmid,jl fehrJL Fehr,h johnH John,dm schmidDM Schmid,jl fehrJL Fehr,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Extraperitoneal radical prostatectomy Da Vinci] Journal Published:

    PUBLICATION TYPE: Review

    Journal: Actas urologicas españolas

    VOLUME: 31

    Page Numbers: 580-6

    Journal Abbreviation:

    ISSN: 0210-4806

    DAY: 27

    MONTH: Jun

    YEAR: 2007

    [Extraperitoneal radical prostatectomy Da Vinci] Information

    Number of References: 11

    LANGUAGE: spa

    NlmUniqueID: 7704993

    [Extraperitoneal radical prostatectomy Da Vinci] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Extraperitoneal radical prostatectomy Da Vinci] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Extraperitoneal radical prostatectomy Da Vinci]

    AFFILIATION: Centro de Urología, Klinik Hirslanden, Universitätsspital Zürich. hubert.john@hirslanden.ch

    Country: Spain

    Spain Research PublicationSpain Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Actas Urol Esp

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Extraperitoneal radical prostatectomy Da Vinci Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News